Johnson & Johnson plans to interrupt up into two firms, splitting off the $15-billion-a-year division that sells Band-Help bandages, Tylenol medicines and Johnson’s Child Powder in a shift indicating simply how a lot healthcare has modified for the reason that firm helped pioneer the business.
The world’s largest health-products firm by gross sales will separate its high-margin however much less predictable prescription-drug and medical-device companies from its storied however slower-growing client group, creating two publicly traded firms.
